Jonathan Wright, Global Managing Director, Dow Jones & Co.
Satish Chander, Partner, True North
The Modi government is on an overdrive to make good on its promise to make healthcare accessible to the underprivileged population. Ayushman Bharat, also dubbed as Modicare, is an ambitious programme that will not only make quality healthcare services available to over 500 million citizens, but will bring in as many customers into mainstream healthcare market and expectedly, open up opportunities worth more than Rs 50,000 crore a year. What will be those opportunities and are service providers ready to top them? What can investors expect?
Harish Pillai, CEO, Aster Hospitals & Clinics, India
Sumit Nadgir, Director, True North
Nitish Agrawal , Managing Director, Indium Capital
Archna Shukla, Editor in Chief, News Corp VCCircle (Moderator)
The fiercely-fought battle to take over Fortis Healthcare, the Rs 4,000-crore entry of Malaysian healthcare behemoth IHH into India and the government’s newly- announced Ayushman Bharat are all likely to push consolidation in the hospitals segment and this warrants a detailed look at the possible scenarios.
Bhavdeep Singh, CEO, Fortis
Vishal Bali, Executive Chairman, Asia Healthcare Holdings (Interviewer)
For healthcare companies, private equity & venture capital investors have been a big force in driving expansion, consolidation and exploration of newer frontiers. Last year, more than $1.3 billion flowed into the sector way of PE/VC capital. Which new segments, geographies and opportunities are they chasing at the moment?
While there has been some action in the diagnostics sector in the recent past, scaling up businesses is something that investors are still wary of. What are the opportunities and the challenges ahead for diagnostics?
New age single specialty themes - mother and child care, oncology care, home healthcare -- have attracted significant funding this year. When are they going to break out?
Rohit MA, Cofounder & Managing Director, Cloudnine Group of Hospitals
Will the Indian pharma industry continue to be king of generic drugs? What is withholding investments in R&D? In which direction is the country’s pharma industry moving?
The government is seeking to cap prices of drugs, devices, services, overall margins and the quality of healthcare. Do service providers see this as a necessity in a market where the majority of the population cannot avail of quality healthcare services, or will it impede their growth?
We bring our Showcase session, a curated platform that brings a set of handpicked innovative healthcare startups to make an elevator pitch to select jury of angel investors, houseful of VCs & fellow entrepreneurs. This is also an opportunity to early stage, pre-revenue, startups as well to grab investor attention. Click here to apply for showcase.
Ramesh Byrapaneni, Managing Director, Endiya Partners
Mayur Sirdesai, Partner, Somerset Indus Capital Partners
Vishal Bali, Senior Healthcare Adviser, TPG Growth
Amit Varma, Managing Partner, Quadria Capital
From online appointments to prescriptions, e-pharmacies to tele-consultation & in-home healthcare to cloud-based health data systems, digital healthcare is plugging gaps in the rural market and delivering convenience to urban customers. How is digital healthcare evolving in India and what is the market opportunity?
Meena Ganesh, CEO & MD, Portea Medical
Ashish Gupta, CEO, DocPrime & CTO, Policybazaar
Amit Mookim, Managing Director, South Asia, IQVIA (Moderator)
Artificial intelligence, machine learning, robotics, Big Data and analytics are increasingly being used, particularly by large hospital chains, to address complicated health issues as well as to streamline regular functions. A look at the transformation big tech is bringing about in healthcare.
Ramesh Byrapaneni, Managing Director, Endiya Partners
Satish ChanderPartner, True North
Satish joined True North in 2005 and is based in Bengaluru. He joined the firm as part of the business management team and worked with companies across healthcare, media, retail and industrials. He is now part of the investment team and is responsible for investments in healthcare sector.
He holds a Mechanical Engineering degree from the IIT, Chennai and a Post Graduate Diploma in Management from the IIM, Kolkata. Prior to joining True North, Satish had six years of experience working with Tata Motors, Accenture and JP Morgan in India.
Bhavdeep SinghCEO, Fortis
Mr Bhavdeep Singh is the CEO of Fortis Healthcare, this being his second stint as the Chief Executive Officer of the organization. At Fortis, Mr. Singh is driving a strong push towards bringing great patient care to every patient in every hospital, every single day. In addition to driving patient care, the clinical team at Fortis is driving clinical excellence on multiple fronts. At a time when the disease burden continues to grow in India, Mr Singh and the Fortis Healthcare team are taking the lead in helping India becoming a healthier nation.
Mr Singh is an acknowledged business leader and a seasoned professional, with over 20 years of experience. He has held senior executive roles in Healthcare, Human Resources and Retail. He has worked across multiple geographies and has a strong track record of building great teams whilst delivering exceptional results.
Prior to joining Fortis, Mr Bhavdeep Singh was with Ahold, a 26 USD billion retailer with almost 800 stores. He was with the company for almost five years and served on the company’s executive board. While there, he was EVP of HR and then went on to head Ahold’s US operations and the new formats business. In addition, prior to his initial stint at Fortis, Mr. Singh ran Reliance Retail in India and was at the helm when Reliance opened up more than 700 new stores in less than two years.
Mr Singh attended Pace University and completed several certified courses in Leadership and Executive Management from premier institutions such as the Harvard Business School, Cornell University, University of Hartford, Dial Institute of Management and St. Joe’s University in the United States.
Amit VarmaManaging Partner, Quadria Capital
Over 25 years of Private Equity, strategic & operational leadership and board level experience in healthcare organizations across USA, Asia and Australia.
Co-founder and Managing Partner of Quadria Capital, one of Asia's largest healthcare private equity firms, with assets under management exceeding US$1.6 billion and focused on investing in the healthcare sector across South and Southeast Asia.
Dr. Varma is also the sponsor of Healthquad, a healthcare focused Venture Capital firm investing in technology backed companies in India, and spearheaded India Build Out Fund, US$100 Mn Healthcare and Education focused domestic Private Equity Fund.
Co-led the deployment of RHC Principal , a US$ 700 Mn principal pool of capital, across various healthcare sub sectors in Asia.
Renowned Critical Care Medicine Physician and continues to practice as a critical care physician on a part-time basis.
Has over 25 years of Private Equity, strategic & operational leadership experience in healthcare organizations across USA, Asia and Australia.
Previously, he has been associated with Fortis Healthcare, Narayan Hrudayalaya and Manipal Heart Foundation.
Has also served as an adjunct professor at the University of Pittsburgh and the Cleveland Clinic.
• M.B.B.S., M.D. from the University of Delhi, India
• Super-specialty medicine training from the University of New York and University of Pittsburgh, USA
• Attended MBA courses at the University of Chicago, USA
Amit MookimManaging Director, South Asia, IQVIA
Amit leads the commercial business for IQVIA across South Asia. Amit’s responsibility is to leverage IQVIA’s global and regional consulting, data and technology assets and people to assist life sciences, medical technology, healthcare and insurance clients. Amit brings with him a deep knowledge and understanding across key areas like new business setup and growth, strategy, M&A and Private Equity.
Prior to IQVIA, Amit was with KPMG India where he was heading the Healthcare vertical. He was one of the youngest Partners in KPMG and helped the firm build and grow the Private Equity Advisory and Strategy business and also the Healthcare Practice for India and across Asia Pacific. Amit worked across 11 countries across India and Asia Pacific as part of this role.
In his career span of 17 years, Amit has set up and led successful teams in Strategy, PE/ M&A Advisory and Healthcare. He has advised Indian and multinational corporations, funding organizations like the World Bank and DFID, Governments, Private Equity and Venture funds and start-ups. He is a part of some of the leading industry bodies such as FICCI, NATHEALTH, and TiE. Amit has also authored a Thought Leadership for the Future of Healthcare forum which was launched by the President of India in 2014.
In his personal capacity, Amit actively promotes the cause of healthcare entrepreneurship in India and is currently mentoring 2 healthcare start-ups to grow and professionalise. As part of his Board role at TiE, a non-profit organization to support entrepreneurship, Amit has created and set up the healthcare start-up community. The role of this community is to mentor new start-ups in Healthcare and provide them access to mentors, industry and funding.
Amit has done his Bachelor in Economics from University of Kolkata and his MBA from FMS, Delhi. Amit believes that fitness and endurance are two key aspects for personality development and is a long distance runner. He has participated in 15 marathon runs in the last 3 years across 3 countries.
Harish PillaiCEO, Aster Hospitals & Clinics, India
A doctor with exceptional leadership skills, Dr. Harish Pillai joined the Aster DM Healthcare Group as the CEO of Aster Medcity, Kochi in the year 2013. His ability to strategize and manage large-scale healthcare organisations helped Aster Medcity consolidate its place among the top hospitals in the country in a matter of just one year.
Subsequently, Dr. Harish Pillai was promoted as the Cluster Head of Aster DM Healthcare in Kerala and Hyderabad which included 5 hospitals. He was also responsible for commissioning the upcoming green-field projects of the group. In April 2018, Dr. Harish Pillai was promoted as the CEO of Aster Hospitals & Clinics in India that is currently spread across 5 states and has 10 hospitals with around 3887 beds and 7 clinics.
An expert in hospital administration, quality and brand management, business strategy, product launches and joint ventures, Dr. Harish Pillai has played a significant role in the development of the healthcare industry in India and the Middle East & North Africa (MENA) by setting new benchmarks in quality and patient care.
Prior to joining Aster DM Healthcare, Dr. Harish Pillai was the CEO of Egypt’s biggest private tertiary care hospital - As Salam International Hospital, Cairo, for over 7 years. He has also been instrumental in implementing several high-value healthcare initiatives in Cairo.
One of the most influential leaders in the Indian healthcare industry, Dr. Harish Pillai is a Member of the Joint Commission International (JCI) Standards Advisory Panel; President of Association of Healthcare Providers (AHPI) – Kerala Chapter; National Co- Chair for Medical Value Travel Committee in Federation of Indian Chambers of Commerce and Industry (FICCI); Elected secretary of the Kerala Medical Value Travel Society (KMVTS); visiting faculty at Tata Institute of Social Sciences (TISS) Mumbai and Administrative Staff College of India (ASCI) Hyderabad.
Dr. Harish Pillai featured on Medgate Today Magazine’s 25 Living Legends in Healthcare in India (May 2016 edition); Healthcare Executive Magazine’s list of top 25 Healthcare Influencers in India (January 2015 edition) and top 10 most influential project heads in the country by Healthcare Radius Magazine (October 2015 edition).
Ramesh ByrapaneniManaging Director, Endiya Partners
For any query, please reach us at firstname.lastname@example.org, +91-9560888566 / +91-120-4171111
There is no cash refund in case you cancel the registration from your end. We will issue a credit note for an equivalent amount which you can adjust/utilise against any of our future events (under the validity period) if the registration is cancelled at least 3 days before the event, post which NO credit note will be issued. Company reserves the right to amend content, expert, policy, venue & date(s) of the conference. Delegates will be refunded the registration fee in full in case the conference gets cancelled from our end.
Substitutions within a company are permitted through the conference date. Shared registrations are not permitted under any circumstances